Groupe Berkem, a leading player in plant-based chemistry, announces the launch of Biombalance, its new range of premium active ingredients for the nutraceuticals market.
Olivier Fahy, Chairman and CEO of Groupe Berkem, comments: "We are particularly proud to be able to offer our customers a range of natural active ingredients with scientifically proven human health benefits. With the launch of Biombalance, we are pursuing the strategy of broadening our offering that we initiated with the acquisition of i.Bioceuticals at the beginning of the year, giving further credibility to our positioning in this fast-growing market. We are convinced that we can make the most of our historic expertise in plant extraction in this business segment, which is particularly stimulated by innovation and attentive to the naturalness of products.
Eric Moussu, Groupe Berkem Sales Director, adds: "This new range of premium active ingredients represents the culmination of long-term work by Groupe Berkem's R&D teams, and once again demonstrates the quality of the solutions we offer to players in the health, beauty & nutrition sectors. Indeed, in addition to reinforcing the group's international development strategy, we are now in a position to offer the nutraceutical market ethically sourced ingredients, rigorously selected for their active molecules with a favorable impact on digestive health and scientifically proven virtues."
Drawing on Groupe Berkem's longstanding expertise in plant extraction and active ingredient development, the Biombalance range of premium ingredients meets the demand for dietary supplements that help balance the intestinal microbiota, a health issue affecting millions of people around the world.1.
Thanks to its in-depth knowledge and expertise of plants and their active molecules, Groupe Berkem has selected ingredients that act on microbiotic balance, restoring the intestinal barrier, reducing oxidative stress and restoring immune tolerance. The flagship product of this new range, Symgrape, is a premium active ingredient derived from the extraction of polyphenols from grape seeds, one of the company's historical activities, themselves rigorously selected, sustainably sourced and endowed with significant scientifically-proven benefits for intestinal health.
With this new range, Groupe Berkem is strengthening its position in the fast-growing nutraceuticals market, and more specifically in the segment of dietary supplements for intestinal health, estimated to be worth $38.8 billion in 2021.2 which is expected to grow by nearly 9 % per year between now and 20313. This product launch also follows on from the acquisition of i.Bioceuticals in February 2023, which gave the Berkem Group a foothold in North America, the world's leading nutraceutical market.4where Groupe Berkem has been distributing its natural active ingredients for decades.
Alongside Symgrape, the Biombalance range includes three additional premium ingredients with recognized benefits for the health of the human microbiota: Symint, Mallowsym and Symthym.
Groupe Berkem will present its new nutraceutical range for dietary supplements on October 25 and 26, 2023 at SupplySideWest in Las Vegas.
1 Lajoie F, et. Al,. Medicine / Science. Irritable bowel syndrome: Role of the intestinal microbiota, 2021. Actif's MAG n°82. Digestive health: active ingredients play the plurality game, 2023.
2 Supplement Business Report, 2023 Informa, Nutritionbusinessjournal ; Actif's MAG n°82. Digestive health: assets play the plurality, 2023.
3 Actif's MAG n°82, Digestive health: active ingredients play the plurality game, 2023.
4 Supplement Business Report, 2023 Informa, Nutritionbusinessjournal.
